Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CGEM
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 9, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 9, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 2, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 2, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 24, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 24, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 14, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 14, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 13, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2026 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 16, 2026 | CGEM Cullinan Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 10, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 10, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 8, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 8, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 18, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 18, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 10, 2026 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 8, 2026 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2026 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 8, 2026 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 8, 2025 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 8, 2025 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 21, 2025 | CGEM Cullinan Therapeutics, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2025 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2025 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 3, 2025 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 3, 2025 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 4, 2025 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 4, 2025 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 7, 2025 | CGEM Cullinan Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 7, 2025 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 12, 2025 | CGEM Cullinan Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 4, 2025 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 4, 2025 | CGEM Cullinan Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 8, 2025 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 27, 2025 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 29, 2025 | CGEM Cullinan Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 29, 2025 | CGEM Cullinan Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 7, 2024 | CGEM Cullinan Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
45 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances